BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reynolds PD, Rhenius ST, Hunter JO. Xanthine oxidase activity is not increased in the colonic mucosa of ulcerative colitis. Aliment Pharmacol Ther. 1996;10:737-741. [PMID: 8899081 DOI: 10.1046/j.1365-2036.1996.57199000.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Najafzadeh M, Reynolds PD, Baumgartner A, Jerwood D, Anderson D. Chaga mushroom extract inhibits oxidative DNA damage in lymphocytes of patients with inflammatory bowel disease. BioFactors 2007;31:191-200. [DOI: 10.1002/biof.5520310306] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
2 Pacher P, Nivorozhkin A, Szabó C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006;58:87-114. [PMID: 16507884 DOI: 10.1124/pr.58.1.6] [Cited by in Crossref: 706] [Cited by in F6Publishing: 541] [Article Influence: 47.1] [Reference Citation Analysis]
3 Ademoglu E, Erbil Y, Tam B, Barbaros U, Ilhan E, Olgac V, Mutlu-Turkoglu U. Do vitamin E and selenium have beneficial effects on trinitrobenzenesulfonic acid-induced experimental colitis. Dig Dis Sci 2004;49:102-8. [PMID: 14992443 DOI: 10.1023/b:ddas.0000011610.47179.0b] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
4 Ko JK, Lam FY, Cheung AP. Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis. World J Gastroenterol. 2005;11:5787-5794. [PMID: 16270386 DOI: 10.3748/wjg.v11.i37.5787] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
5 Kruidenier L, Kuiper I, Lamers CB, Verspaget HW. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol. 2003;201:28-36. [PMID: 12950014 DOI: 10.1002/path.1409] [Cited by in Crossref: 239] [Cited by in F6Publishing: 225] [Article Influence: 13.3] [Reference Citation Analysis]
6 Karp SM, Koch TR. Oxidative Stress and Antioxidants in Inflammatory Bowel Disease. Disease-a-Month 2006;52:199-207. [DOI: 10.1016/j.disamonth.2006.05.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
7 Zhu F, Feng D, Zhang T, Gu L, Zhu W, Guo Z, Li Y, Lu N, Gong J, Li N. Altered uric acid metabolism in isolated colonic Crohn's disease but not ulcerative colitis. J Gastroenterol Hepatol 2019;34:154-61. [PMID: 29926959 DOI: 10.1111/jgh.14356] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hamer HM, Jonkers DM, Bast A, Vanhoutvin SA, Fischer MA, Kodde A, Troost FJ, Venema K, Brummer RJ. Butyrate modulates oxidative stress in the colonic mucosa of healthy humans. Clin Nutr. 2009;28:88-93. [PMID: 19108937 DOI: 10.1016/j.clnu.2008.11.002] [Cited by in Crossref: 193] [Cited by in F6Publishing: 162] [Article Influence: 14.8] [Reference Citation Analysis]
9 Koch TR, Yuan LX, Stryker SJ, Ratliff P, Telford GL, Opara EC. Total antioxidant capacity of colon in patients with chronic ulcerative colitis. Dig Dis Sci 2000;45:1814-9. [PMID: 11052325 DOI: 10.1023/a:1005517824877] [Cited by in Crossref: 47] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]